Desoximetasone

Cat. No.: OB0225WX-2632

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Desoximetasone is a synthetic agonist of the glucocorticoid receptor that modulates metabolic, immunosuppressive, and anti-inflammatory signaling.

Synonym: Desoxymethasone; Desoximetasonum; 382-67-2; Topicort; Desoximetasona; Desoximetasonum; Topicort LP; 17-Deoxydexamethasone; Desoxymetasone; Flubason; Desossimetasone; Esperson; HOE-304; 17-Deoxymethansone; 17-Desoximethasone; HOE 304; Deoxymethasone; 9-Fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one; 9alpha-fluoro-16alpha-methyl-Delta(1)-corticosterone; 17 Desoxymethasone; 17-Desoxymethasone; A-41304; (11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione; (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; 9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)-; 9alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1.4-pregnadiene-3,20-dione; (1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one; (1S,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-10-hydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one

CAS No.: 382-67-2

Compound CID: 5311067

Formula: C₂₂H₂₉FO₄

Formula Weight: 376.46

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Desoximetasone is used in dermatological pharmacology as a potent glucocorticoid to investigate the regulation of inflammatory mediators and the reduction of epidermal hyperproliferation in topical disease models.